A treatment plan can improve sleep and reduce breathing interruptions, but the right approach depends on the reason those interruptions happen. Some pauses come from a blocked airway; others happen when the brain does not signal the body to breathe. People may face loud snoring, restless nights, or daytime sleepiness, and each symptom can affect daily life.
Care may include positive airway pressure, lifestyle changes, oral devices, medication, or procedures. The choice depends on the apnea type, its severity, health needs, comfort, and cost. We can expect some trial and adjustment with a clinician, rather than one instant fix. A sleep study and a conversation with a qualified healthcare professional are practical starting points.
Key Takeaways
- Sleep studies help identify the type and severity of breathing events.
- PAP is a common treatment, but masks and settings may need adjustment.
- Oral devices, medicine, and procedures can suit some people.
- Lifestyle changes can support care but do not always replace it.
- Coverage, supplies, and follow-up affect the total cost.
How do we identify the type and severity?
The first step is confirming whether breathing interruptions come from a blocked airway, a problem with breathing signals, or both. A sleep study can show the pattern and severity of events, which guides the next decision.
The apnea-hypopnea index (AHI) is the average number of times per hour that breathing stops or becomes shallow during sleep. Obstructive sleep apnea (OSA) involves repeated upper-airway blockage, while central sleep apnea (CSA) occurs when the brain does not send the signals needed to breathe. For OSA, diagnosis generally requires 15 or more obstructive events per hour, or at least five with symptoms or related health conditions.
Snoring alone does not establish OSA; a clinician must assess sleep-study results and relevant symptoms or health conditions.
Common symptoms include loud snoring, witnessed pauses, gasping, and daytime sleepiness. A polysomnogram is an overnight sleep study, while a home sleep apnea test is another diagnostic option. A clinician reviews the test and the person’s health history before making a diagnosis.
A bed partner may notice events that the sleeper cannot recall. Those observations can help the clinician compare symptoms with the sleep study, especially when breathing changes seem to vary through the night.
Bring a bed partner’s observations about pauses, gasping or unusual breathing to the clinician assessing the sleep study.
How do PAP devices keep the airway open?
PAP therapy uses pressurized air as an internal support to help keep the upper airway open during sleep. A mask connects by hose to a bedside machine, which sends air through the nose, mouth, or both. The mask style and pressure pattern depend on the person’s needs.
CPAP keeps one steady pressure, APAP adjusts pressure automatically, and BPAP uses different pressures for breathing in and out. A sleep clinician selects the device and its settings based on the breathing pattern and clinical needs.
| Device | Pressure pattern | Typical use |
|---|---|---|
| CPAP | One continuous pressure during inhaling and exhaling | Common therapy for OSA when a steady pressure is prescribed |
| APAP | Pressure shifts automatically within a prescribed range | Used when pressure needs change during sleep |
| BPAP | Higher pressure for inhaling and lower pressure for exhaling | May suit people who need two pressure levels |
Continuous positive airway pressure (CPAP) is the familiar form of PAP, but it is not the only one. Automatic positive airway pressure (APAP) can respond to changing needs within a clinician-set range. Bilevel positive airway pressure (BPAP) has separate pressure levels for each part of the breath.
Sleep apnea treatment devices may use masks that cover the nose, the mouth, or both. A good fit helps limit air leaks and keeps the mask more comfortable. The machine does not replace clinical care; it delivers the prescribed air support.
People should not change pressure ranges or switch modes on their own. The best device setting is the one prescribed for the individual’s breathing pattern and clinical needs.
What can PAP improve, and what makes it hard to use?
Many people feel less sleepy and function better during the day when PAP works for them, but use and outcomes differ by person. CPAP can improve sleep-related quality of life and blood pressure, too. Its effect on heart health depends on each person’s risk and health history.
In people with high-risk OSA and cardiovascular disease, CPAP use was linked with a 17% lower risk of heart attack, stroke, or cardiovascular death over an average three-year follow-up. Another pooled analysis found a 22% higher risk of serious cardiovascular events among participants without high-risk OSA. That finding applied to non-sleepy people with existing heart disease in the analyzed trials, not to every CPAP user.
Those study results describe groups, not a personal prediction or a reason to stop treatment. Regular use can be difficult when a mask feels awkward, the nose or mouth becomes dry, or pressure feels uncomfortable.
We can use a few checks to find common barriers:
- Check whether the mask fits without leaks or painful pressure.
- Tell the care team about nasal or mouth dryness.
- Ask whether the pressure feels comfortable through the night.
- Schedule follow-up with the care team when problems persist.
Medicare coverage rules for CPAP use a benchmark of at least four hours on 70% of nights. That is a coverage measure, not the ideal amount of sleep-time treatment. We should aim to use PAP for the full sleep period when possible.
Tell the prescribing clinician about discomfort early, since mask or setting adjustments can make regular use more manageable.
Which lifestyle changes can support treatment?
Lifestyle changes can support sleep apnea treatment, especially when they address a factor that worsens airway obstruction. They may help alongside prescribed care, but do not guarantee that breathing events will go away.
Useful home steps can support a diagnosis-based plan, but they are not proven substitutes for treatment prescribed to match the diagnosis. We can focus on habits that are practical enough to keep doing.
- Work toward sustainable weight management when weight affects OSA.
- Exercise regularly, since activity may help even without weight change.
- Try side-sleeping when events are worse while sleeping on the back.
- Limit alcohol near bedtime, since it can worsen obstructive breathing.
Weight changes may affect breathing, but results differ across people. In one longitudinal study, a 10% weight loss predicted a 26% drop in AHI. That finding describes a study result, not a guaranteed change for each person.
Position can matter, too. The AHI has been observed to be twice as high when people sleep on their backs as when they sleep on their sides. This pattern does not apply to every person, so a clinician can help determine whether positional OSA is involved.
The National Heart, Lung, and Blood Institute lists lifestyle changes and CPAP devices among common sleep apnea treatments. A supportive habit may improve health even when it does not resolve the apnea.
Keep using prescribed treatment unless the clinician who manages it confirms that a change is appropriate.
What can we try without PAP?
A custom oral appliance is a common alternative when PAP is not a workable fit, particularly for mild or moderate OSA. A dentist trained in sleep appliances can assess the teeth and jaw, then fit a device that changes the position of the jaw or tongue. The goal is to improve airflow, not merely quiet snoring.
An oral appliance may also suit someone with severe OSA who refuses or cannot tolerate CPAP, but it still needs dental assessment and follow-up. Two common designs work in different ways.
Custom oral appliances
A mandibular advancement device moves the lower jaw forward to help keep the airway open. A tongue-retaining device holds the tongue forward instead. Dental health affects whether a person can use either type, and the appliance may cause tooth soreness or jaw discomfort.
Reported success was 68% after two years in one study and 69% in another, using a 50% AHI reduction as the measure. These results do not mean every user will respond. Dental follow-up is recommended every six months during the first year, then once a year.
Other nonsurgical device and muscle therapies
Nasal expiratory positive airway pressure (EPAP) devices use resistance as a person breathes out through the nose. Oral negative-pressure therapy, such as iNAP, uses suction in the mouth to help draw the tongue and soft tissue forward. These options do not fit every person.
Tongue-muscle stimulation devices, including eXciteOSA, aim to strengthen or activate muscles that help keep the airway open. In one study, eXciteOSA changed average AHI from 10.2 to 6.8 events per hour. Myofunctional therapy uses exercises for the tongue and other mouth muscles; a systematic review reported a 50% AHI reduction.
These therapies suit different patients, and their evidence and use can vary. Objective follow-up testing helps show whether breathing events improved. Ask the sleep clinician and dentist how they will verify that a mouthpiece is reducing breathing events, not just snoring.
Can Sleep Apnea Treatment Include Zepbound?
Zepbound is the first FDA-approved medication specifically indicated for adults with obesity and moderate-to-severe OSA. It contains tirzepatide and is used with reduced-calorie eating and increased physical activity. The FDA approved it for this use on December 20, 2024.
This approval makes Zepbound a medicine for sleep apnea treatment in a defined group. Other medicines are not interchangeable FDA-approved treatments for OSA. The trial results show possible changes in a study group, not a promise that each person will reach remission or stop PAP.
What the OSA trials measured
The approval relied on two randomized, double-blind, placebo-controlled trials with 469 adults who did not have type 2 diabetes. One trial included people using PAP, while the other included people unable or unwilling to use PAP. Participants received 10 or 15 milligrams once weekly for 52 weeks.
After 52 weeks, breathing disruptions fell by 25-29 per hour with Zepbound, compared with 5-6 per hour with placebo. Remission or mild OSA occurred in 42% of participants not using PAP and 50% using PAP with Zepbound. The matching placebo groups had rates of 16% and 14%.
Average weight loss was 18-20%, or 45-50 pounds, with Zepbound. Placebo participants lost 2%, or 4-6 pounds. The treatment aims to reduce disease burden, but these results do not show that every person can stop PAP or avoid other care.
Who should discuss safety before treatment
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, and injection-site reactions. Other listed effects can occur, so a prescriber should review the full medication information and the person’s health history.
Zepbound should not be used by someone with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2 (MEN2), or a severe allergic reaction to tirzepatide. FDA warnings include pancreatitis, gallbladder problems, low blood sugar, kidney injury, diabetic retinopathy in people with type 2 diabetes, suicidal thoughts or behavior, and aspiration risks during anesthesia or deep sedation.
Review personal risks, current medicines and treatment goals with a prescriber before starting or stopping tirzepatide.
When is sleep apnea surgery considered?
Surgery is usually considered when less invasive treatment has not worked or when a clinician identifies an anatomical problem that can be corrected. A clear structural cause can make surgery relevant before someone has tried every other option.
Surgery may improve airflow, but it does not guarantee that OSA will end. Procedures can target different areas of the nose, throat, or jaw.
- Soft-palate surgery, such as uvulopalatopharyngoplasty (UPPP).
- Tonsil or adenoid removal when those tissues block airflow.
- Tongue or other throat procedures to open the upper airway.
- Jaw advancement to move the airway-supporting structures forward.
- Nasal procedures that improve airflow or support another treatment.
The National Heart, Lung, and Blood Institute lists surgery as a possible recommendation when CPAP and lifestyle changes do not work. A surgical team can assess where the airway narrows and whether a procedure may address it.
Bariatric surgery may reduce OSA linked to obesity, but breathing problems can remain. In one study, moderate or severe OSA persisted in 20% of patients after weight-loss surgery. Another study found median CPAP use after bariatric surgery was 49% of nights.
Follow-up matters even after weight changes or an operation. A new sleep study can show whether apnea remains and whether treatment needs to continue.
Ask the surgical team how success will be measured and what follow-up testing will confirm the result.
Who may qualify for hypoglossal nerve stimulation?
HNS is an implanted option for selected people with moderate-to-severe OSA who cannot use or tolerate PAP. The system senses breathing and sends electrical impulses to nerves that help keep the upper airway open. Inspire’s FDA criteria include age 22 or older, AHI 15-100, PAP or BiPAP intolerance, and no complete concentric soft-palate collapse.
Inspire should not be used when central and mixed apnea make up more than 25% of total AHI. In June 2023, the FDA raised Inspire’s upper baseline AHI limit to 100 and its recommended upper BMI limit to 40. A person turns the implant on before sleep and off when awake with a remote.
Eligibility and how the implant works
Hypoglossal nerve stimulation (HNS) uses an implant to detect breathing and stimulate nerves that move the tongue and support an open airway. A specialist checks the sleep study and airway anatomy. The FDA criteria for Inspire also require that the person cannot use or tolerate PAP or BPAP.
Eligibility rules can differ by device and may change. A drug-induced sleep endoscopy can help assess whether the soft palate has complete concentric collapse. The Inspire criteria also exclude people whose central and mixed events exceed one-quarter of total AHI.
How the FDA-approved systems differ
A 2026 American Academy of Sleep Medicine overview lists Inspire, Genio 2.1, and Aura6000 for moderate-to-severe OSA after PAP failure. Its comparison lists different age, AHI, and BMI limits, plus different implant designs and outcomes.
| Device | AHI/age/BMI | System details | AHI response | Re-intervention |
|---|---|---|---|---|
| Inspire V | 15-100; age 18+; BMI 40 | Breathing-synchronized; 10-year battery | 66% | 2% |
| Genio 2.1 | 15-65; ages 22-75; BMI 32 | Bilateral implant; wearable charged daily | 64% | 3% |
| Aura6000 | 15-65; ages 22-75; BMI 35 | No drug-induced sleep endoscopy requirement to exclude complete concentric collapse; 15-year battery | 58% | 11% |
The FDA Inspire criteria state age 22 or older, while the 2026 comparison lists Inspire V from age 18. These are distinct criteria, not a single rule. A specialist can confirm the current device-specific limits before considering an implant.
What is the newest treatment for sleep apnea?
Recent treatment advances include Zepbound for certain adults with obesity and OSA, plus several HNS systems with different designs. No single option is the newest or best choice for everyone. The right fit depends on the diagnosis, health needs, and the specific device rules.
Eligibility requires a sleep specialist to review the sleep study and airway anatomy, not BMI or symptoms alone.
What affects sleep apnea treatment costs?
The most affordable option upfront may not be the least expensive over time, since fitting, supplies and follow-up add to treatment costs. Typical U.S. self-pay ballparks range from about $500 for CPAP equipment to tens of thousands of dollars for implant surgery. These are general estimates, not quotes or promises.
Insurance, deductibles, provider fees, equipment choices, and follow-up needs can change what a person pays. A custom oral appliance also involves dental assessment and fitting. Implant care may include testing, a facility fee, and follow-up visits.
| Treatment | Broad U.S. self-pay range | Main cost drivers |
|---|---|---|
| CPAP equipment | About $500-$1,000 | Machine, mask, hose, supplies, and replacement needs |
| Custom oral appliance | About $1,500-$3,000 | Dental fitting, device type, and follow-up visits |
| Implant surgery | Tens of thousands of dollars before insurance | Testing, surgeon, facility, implant, and follow-up care |
The total bill may include a sleep study, clinician visits, fitting, equipment, and supplies. Replacement schedules and coverage rules can also affect the long-term cost. A low upfront price does not show the full cost of ongoing care.
Zepbound costs are not included in these treatment ranges. Coverage for medication, PAP supplies, dental devices, and surgery can differ across plans. We can ask about each part before choosing an option.
Ask the insurer and care team which services and replacement supplies are covered before agreeing to a treatment.
How is central sleep apnea treated differently?
Central sleep apnea is not simply a throat blockage, so its treatment focuses on the cause and the pattern of breathing. In CSA, the brain does not send the signals needed to breathe; OSA involves repeated blockage of the upper airway. A clinician needs to identify the type of event before choosing treatment.
Care often starts with a review of health conditions and medicines that may affect breathing. A clinician familiar with the cause can decide which treatment fits. Some CSA cases may be managed with breathing devices such as adaptive servo-ventilation, but a specialist must assess whether that option suits the person.
Oxygen alone should not be treated as a substitute for OSA care. It does not address an obstructed airway in the same way as treatment designed to manage OSA. A clinician should consider the full breathing pattern before recommending oxygen or another device.
Acetazolamide has been studied for CSA, with one study finding a 42% AHI reduction. It is not a self-treatment or a general FDA-approved medicine for OSA. A European Respiratory Society guideline gave carbonic anhydrase inhibitors a conditional recommendation only in randomized trials.
Because CSA and OSA have different causes, one treatment plan may not suit both. Mixed events also need careful review, especially before someone changes a device setting or medicine.
Ask the clinician to confirm whether events are obstructive, central or mixed before changing a breathing device or medicine.
How do we choose a plan with our healthcare team?
A useful treatment choice fits both the diagnosis and the person’s ability to use it consistently. A sleep physician, dentist experienced in oral appliances, or surgeon may help, depending on the option. Shared decisions should weigh clinical fit, comfort, cost, and daily routine.
Bring clear information to the appointment so the team can connect the sleep-study result with daily symptoms. A polysomnogram and a home sleep apnea test are both diagnostic tools. The treatment team may include more than one type of healthcare professional.
- Bring the sleep-study result, including the test date and findings.
- Describe symptoms and daytime effects, such as sleepiness at work.
- List past treatments and barriers, including discomfort or poor fit.
- Share relevant health conditions and all current medicines.
- Ask how success will be measured and when follow-up will occur.
These details help the team compare options against real needs, not just test numbers. A dentist can assess whether teeth and jaw can support an oral appliance. A surgeon may review anatomy when a procedure is under consideration.
We should leave with a clear plan for checking the result. Before leaving the appointment, agree on who will review the results and when treatment effectiveness will be checked.
Conclusion
The most useful treatment is one that fits the diagnosis, addresses the person’s needs and can be followed consistently. Care depends on whether events are obstructive, central, or mixed, as well as their severity and the person’s health.
PAP is not the only option when it is not a workable fit. Oral devices, medicine, lifestyle support, and procedures may be considered with qualified healthcare professionals.
We can take our sleep-study results and treatment concerns to a sleep clinician. We can start by booking a discussion with a sleep clinician and asking how to confirm that the chosen treatment is working.